Cosmos Health announces contract manufacturing agreement with Humacology

Cosmos Health announced that its wholly-owned subsidiary, Cana Laboratories, has secured a contract manufacturing agreement with Australian-based wellness company Humacology. “Humacology is currently embarking on a global expansion drive and has entrusted Cana to manufacture up to 500,000 units of its CBD products. This is the second consecutive agreement announced by Cana over the past week, following its previously announced contract manufacturing agreement with Provident Pharmaceuticals for 4.32 million units of DE3-SOLE, which is used to address vitamin D deficiency by helping the body absorb calcium and promote overall health,” the company stated. Greg Siokas, CEO of Cosmos Health, added: “We are currently scaling up our high-margin contract manufacturing business at a rapid pace, as evidenced by our back-to-back agreements with Humacology and Provident. Cosmos is close to securing several more highly profitable contract manufacturing agreements and will provide updates as soon as any new agreements materialize.”